Customized cutoff limits for the sediMAX-2 automated analyzer reduce the number of urine culture tests

Customized cutoff limits for the sediMAX-2 automated analyzer reduce the number of urine culture tests

Authors

  • Davide Ferrari University of Parma
  • Mladen Trbos San Raffaele Hospital, Milan, Italy
  • Matteo Vidali Clinical Pathology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Massimo Locatelli San Raffaele Hospital, Milan, Italy

Keywords:

SediMax, urinary tract infection, automated urinalysis, customized cutoff

Abstract

Background. Urinary tract infections are highly prevalent in nosocomial and community settings. Their diagnosis, although costly and time-consuming, is crucial to avoid inappropriate treatments and/or clinical complications. In this context, automated analyzers have been developed and commercialized to screen and rule out negative urine samples. Adjustments of the manufacturers’ suggested cutoff values might lead to substantial diagnostic and economic advantages.

Methods. We retrospectively analyzed 776 urine samples from different individuals. 546 samples (training group) were used to optimize develop new cutoffs values. The remaining 230 samples (validation group) were used to validate the optimized cutoffs. All samples were subjected to urine culture, 17% resulted positive. Escherichia coli and Enterococcus faecalis were the two most frequently identified bacteria, 95 and 9 samples, respectively.

Results. Two different cutoffs levels were obtained. Cutoff-A (bacteria>110 and/or white blood cells> 15 cell/µL), showed the same sensitivity of the manufacturers’ suggested cutoff, yet leads to a large reduction of the samples to be cultured. Cutoff-B (bacteria>50 and/or white blood cells>20 cell/µL), showed an almost 100% sensitivity by subjecting only ~70% of the samples to urine culture.

Conclusion. Cutoff-A is a good compromise between sensitivity and specificity yet allowing economic advantages by reducing the number of urinary cultures. Cutoff-B relegates urinary tract infection misdiagnosis to a rare event without the need of culturing the entire batch of samples. We believe that clinical implementation of the proposed cutoffs will help other laboratories, using similar instrumentation, to reach their most convenient balance between sensitivity and economical needs.

References

Kim H, Ryoun Kim H, Kim TH, Lee MK. Age-Specific Cutoffs of the Sysmex UF-1000i Automated Urine Analyzer for Rapid Screening of Urinary Tract Infections in Outpatients. Ann Lab Med. 2019;39(3):322–6.

Íñigo M, Coello A, Fernández-Rivas G, Carrasco M, Marcó C, Fernández A, et al. Evaluation of the SediMax automated microscopy sediment analyzer and the Sysmex UF-1000i flow cytometer as screening tools to rule out negative urinary tract infections. Clin Chim Acta [Internet]. 2016;456:31–5. Available from: http://dx.doi.org/10.1016/j.cca.2016.02.016

Peleg AY, Hooper DC. Hospital-Acquired Infections Due to Gram-Negative Bacteria. N Engl J Med. 2010;362(19):1804–13.

Butler CC, Hawking MKD, Quigley A, McNulty CAM. Incidence, severity, help seeking, and management of uncomplicated urinary tract infection: A population-based survey. Vol. 65, British Journal of General Practice. 2015. p. e702–7.

Meister L, Morley EJ, Scheer D, Sinert R. History and physical examination plus laboratory testing for the diagnosis of adult female urinary tract infection. Acad Emerg Med. 2013;20(7):632–45.

Roberts KB. The Diagnosis of UTI: Liquid Gold and the Problem of Gold Standards. Pediatrics. 2015;135(6):1126–7.

Jolkkonen S, Paattiniemi EL, Kärpänoja P, Sarkkinen H. Screening of urine samples by flow cytometry reduces the need for culture. J Clin Microbiol. 2010;48(9):3117–21.

Egido P, López C, Millán-Lou MI, Ruiz-Andrés MA, Revillo MJ, Rezusta A, et al. Comparing Two Automated Techniques for the Primary Screening-Out of Urine Culture. Front Med. 2018;5(December):1–6.

Choe HS, Lee SJ, Cho YH, Çek M, Tandoğdu Z, Wagenlehner F, et al. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). J Infect Chemother. 2018;24(4):278–83.

Stürenburg E, Kramer J, Schön G, Cachovan G, Sobottka I. Detection of significant bacteriuria by use of the iQ200 automated urine microscope. J Clin Microbiol. 2014;52(8):2855–60.

Delanghe J. New screening diagnostic techniques in urinalysis. Vol. 62, Acta Clinica Belgica. 2007. p. 155–61.

Patel HD, Livsey SA, Swann RA, Bukhari SS. Can urine dipstick testing for urinary tract infection at point of care reduce laboratory workload? J Clin Pathol. 2005;58(9):951–4.

Bhavsar T, Potula R, Jin M, Truant AL. Predictability of urinalysis parameters in the diagnosis of urinary tract infection: a case study. MLO Med Lab Obs [Internet]. 2015;47(1):8, 10, 12; quiz 13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26281112

Van Nostrand JD, Junkins AD, Bartholdi RK. Poor predictive ability of urinalysis and microscopic examination to detect urinary tract infection. Am J Clin Pathol. 2000;113(5):709–13.

Wang J, Zhang Y, Xu DW, Shao W, Lu Y. Evaluation of the sysmex UF-1000i for the diagnosis of urinary tract infection. Am J Clin Pathol. 2010;133(4):577–82.

Oyaert M, Delanghe J. Progress in automated urinalysis. Ann Lab Med. 2018;39(1):15–22.

Zaman Z, Fogazzi GB, Garigali G, Croci MD, Bayer G, Kránicz T. Urine sediment analysis: Analytical and diagnostic performance of sediMAX® - A new automated microscopy image-based urine sediment analyser. Clin Chim Acta [Internet]. 2010;411(3–4):147–54. Available from: http://dx.doi.org/10.1016/j.cca.2009.10.018

Zaman Z, Roggeman S, Cappelletti P, Ferrai G, Buxeda M, Barba N. Evaluation of Aution Max AX-4280 automated urine test-strip analyser. Clin Chem Lab Med. 2001;39(7):649–57.

Martinez MHM, Bottini P V., Levy CE, Garlipp CR. UriSed as a screening tool for presumptive diagnosis of urinary tract infection. Clin Chim Acta. 2013;425:77–9.

Macvane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med. 2014;9(4):232–8.

Esteve-Palau E, Solande G, Sánchez F, Sorlí L, Montero M, Güerri R, et al. Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study. J Infect. 2015;71(6):667–74.

Richards KA, Cesario S, Best SL, Deeren SM, Bushman W, Safdar N. Reflex urine culture testing in an ambulatory urology clinic: Implications for antibiotic stewardship in urology. Int J Urol. 2019;26(1):69–74.

Sala MR, Brambilla P, Venturi N, Falbo R, Signorini S, Signorelli S. Bacteriuria Screening by Automated Whole-Field-Image-Based Microscopy Reduces the Number of Necessary Urine Cultures. J Clin Microbiol. 2012;50(4):1427–9.

European Confederation of Laboratory Medicine. European urinalysis guidelines. Scand J Clin Lab Invest Suppl [Internet]. 2000;231:1–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12647764

Downloads

Published

17-10-2023

Issue

Section

ORIGINAL CLINICAL RESEARCH

How to Cite

1.
Ferrari D, Trbos M, Vidali M, Locatelli M. Customized cutoff limits for the sediMAX-2 automated analyzer reduce the number of urine culture tests. Acta Biomed [Internet]. 2023 Oct. 17 [cited 2024 Jul. 17];94(5):e2023192. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/14951